The US Pharmacopeial Convention (USP) is recalling USP 33?NF 28. The official date for USP 33–NF 28 to go into effect was 1 May 2010. According to a public notice of 12 January 2010, the redesign of ...

Ganeden Biotech is pleased to announce that GanedenBC 30 (Bacillus coagulans GBI-30, 6086) is the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S.

Rockville, Md., March 17, 2008 — The U.S. Pharmacopeial (USP) Convention today announced a revised Glycerin monograph in the United States Pharmacopeia (USP), an official compendium of the United ...

In a letter sent on Wednesday, March 28, 2018, to the CEO of the United States Pharmacopeial Convention, FDA’s Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research, and Dr.

Rockville, Md., November 15, 2007 — The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment. Six Turmeric-related monographs ...

Metrohm USA is proud to partner with the United States Pharmacopeia (USP) and host a webinar describing the USP monograph modernization program and the impact of this program for analytical ...

Atorvastatin, a widely prescribed statin drug, is used to lower cholesterol levels and reduce the risk of cardiovascular diseases.1,2 To ensure the safety and efficacy of this drug, it is essential to ...

A new study released in the journal PLOS One found that on average, drugs with a public quality standard developed by the U.S. Pharmacopeia had approximately 50% more generic manufacturers compared ...

This new application from Dionex, AN 257: HPLC Assay Method for Drug Products Containing Anti-Tuberculosis Active Pharmaceutical Ingredients, uses the hydrolytic-stability-enhanced Acclaim® ...

Utilizing the United States Pharmacopeia and National Formulary (USP-NF) monographs enables pharmaceutical labs and manufacturers to meet strict quality regulations regarding drugs and formulations.